INT305204

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.27
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 3
Disease Relevance 0.60
Pain Relevance 0.27

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Epo) aging (Epo) extracellular region (Epo)
Pbrgcsf1 (Mus musculus)
Epo (Rattus norvegicus)
Pain Link Frequency Relevance Heat
ischemia 69 96.00 Very High Very High Very High
cytokine 24 83.12 Quite High
imagery 18 16.12 Low Low
bDMF 15 5.00 Very Low Very Low Very Low
Glutamate 6 5.00 Very Low Very Low Very Low
Eae 6 5.00 Very Low Very Low Very Low
Hippocampus 6 5.00 Very Low Very Low Very Low
cerebral cortex 3 5.00 Very Low Very Low Very Low
anesthesia 3 5.00 Very Low Very Low Very Low
positron emission tomography 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cv Unclassified Under Development 33 96.00 Very High Very High Very High
Neutropenia 6 89.60 High High
Hypoxia 36 70.28 Quite High
Hematological Disease 3 52.24 Quite High
Stroke 21 44.80 Quite Low
Apoptosis 24 35.36 Quite Low
Myelodysplastic Syndromes 6 28.12 Quite Low
Anaemia 3 26.76 Quite Low
Cv General 4 Under Development 33 5.00 Very Low Very Low Very Low
Targeted Disruption 21 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Here we have demonstrated for the first time that G-CSF enhances the synthesis of EPO via upregulation of HIF-1?
G-CSF Positive_regulation (enhances) of Gene_expression (synthesis) of EPO
1) Confidence 0.27 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2852409 Disease Relevance 0.19 Pain Relevance 0.04
In this study, we intended to demonstrate that G-CSF upregulates EPO expression via the induction of HIF-1?
G-CSF Positive_regulation (upregulates) of Gene_expression (expression) of EPO
2) Confidence 0.18 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2852409 Disease Relevance 0.23 Pain Relevance 0.12
To evaluate whether subcutaneous injection of G-CSF for 5 consecutive days could enhance EPO production in humans, serum EPO levels of human donors (n?
G-CSF Positive_regulation (enhance) of Gene_expression (production) of EPO
3) Confidence 0.18 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2852409 Disease Relevance 0.17 Pain Relevance 0.12

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox